2nd Quarter - Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$1,400,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 668 (112th), H.R. 452 (112th), H.R. 5 (112th)

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); permanent normal trade relations with Russia (no specific bill); non-tariff trade barriers on U.S. beef (no specific bill)

LobbyistCovered position, as disclosed
ELI JOSEPH —
ROBERT MCMAHON —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), H.R. 5651 (112th), H.R. 2245 (112th), S. 296 (112th)

Taxation/Internal Revenue Code TAX

Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).

LobbyistCovered position, as disclosed
ANNE ESPOSITO —
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5651 (112th), S. 3187 (112th), H.R. 2182 (112th)

Consumer Issues/Safety/Products CSP

Access to over-the-counter medications (no specific bill)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.